NfL can also serve as a biomarker for patients with altered consciousness to differentiate between structural brain diseases such as ischemic stroke, viral encephalitis, and nonstructural brain diseases such as epilepsy and psychiatric disorders (Ongphichetmetha et al., 2023). This evidence concerns the gene NEFL and epilepsy.